BRCA1 and BRCA2 gene mutation analysis: Visit to the Breast Cancer Information Core (BIC)

被引:0
|
作者
Shen, DJ [1 ]
Vadgama, JV [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Charles R Drew Univ Med & Sci, Dept Med,Div Lab Res & Dev,Mol Oncol Program, Los Angeles, CA 90059 USA
关键词
BRCA1; BRCA2; mutation; Breast Cancer Information Core (BIC);
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is a leading cancer in American women. About 7% of breast cancer is due to inheritance of mutated genes BRCA1 and BRCA2. Numerous investigations have revealed a number of mutations in BRCA1 and BRCA2 genes. The inheritance of the mutated BRCA1 or BRCA2 genes accounts for 45% and 35%, respectively, of hereditary breast cancers. A central database named Breast Cancer Information Core (BIC) has been established in the National Human Genome Research Institute (NHGRI) to coordinate the information related with BRCA1 and BRCA2 research. Nearly half of the mutations (49%) in the BRCA1 gene are frameshift mutations and the cancer-causing mutations account for 66% of all entries. However, for the BRCA2 gene frameshift mutations and cancer-causing mutations account for only 35% and 43%, respectively, of all entries. The significance of a large portion of missense sequence variants (24% of BRCA1 mutations and 47% of BRCA2 mutations) needs further evaluation. The incidence of 185delAG and 5382insC in BRCA1 gene and 6174delT in BRCA2 gene is predominantly high and the founder effect of these mutations is discussed.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 50 条
  • [21] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Joanne Kotsopoulos
    Jacek Gronwald
    Tomasz Huzarski
    Amber Aeilts
    Susan Randall Armel
    Beth Karlan
    Christian F. Singer
    Andrea Eisen
    Nadine Tung
    Olufunmilayo Olopade
    Louise Bordeleau
    Charis Eng
    William D. Foulkes
    Susan L. Neuhausen
    Carey A. Cullinane
    Tuya Pal
    Robert Fruscio
    Jan Lubinski
    Kelly Metcalfe
    Ping Sun
    Steven A. Narod
    Breast Cancer Research and Treatment, 2023, 201 : 257 - 264
  • [22] Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Kelly Metcalfe
    Henry T. Lynch
    Parviz Ghadirian
    Nadine Tung
    Charmaine Kim-Sing
    Olufunmilayo I. Olopade
    Susan Domchek
    Andrea Eisen
    William D. Foulkes
    Barry Rosen
    Danny Vesprini
    Ping Sun
    Steven A. Narod
    Breast Cancer Research and Treatment, 2011, 127 : 287 - 296
  • [23] Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, Joanne
    Lubinski, Jan
    Salmena, Leonardo
    Lynch, Henry T.
    Kim-Sing, Charmaine
    Foulkes, William D.
    Ghadirian, Parviz
    Neuhausen, Susan L.
    Demsky, Rochelle
    Tung, Nadine
    Ainsworth, Peter
    Senter, Leigha
    Eisen, Andrea
    Eng, Charis
    Singer, Christian
    Ginsburg, Ophira
    Blum, Joanne
    Huzarski, Tomasz
    Poll, Aletta
    Sun, Ping
    Narod, Steven A.
    BREAST CANCER RESEARCH, 2012, 14 (02):
  • [24] Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Ahmed, M.
    Lalloo, F.
    Howell, A.
    Evans, D. G.
    BREAST CANCER RESEARCH, 2010, 12 : S6 - S6
  • [25] Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, Kelly
    Lynch, Henry T.
    Ghadirian, Parviz
    Tung, Nadine
    Kim-Sing, Charmaine
    Olopade, Olufunmilayo I.
    Domchek, Susan
    Eisen, Andrea
    Foulkes, William D.
    Rosen, Barry
    Vesprini, Danny
    Sun, Ping
    Narod, Steven A.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (01) : 287 - 296
  • [26] Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Graeser, Monika K.
    Engel, Christoph
    Rhiem, Kerstin
    Gadzicki, Dorothea
    Bick, Ulrich
    Kast, Karin
    Froster, Ursula G.
    Schlehe, Bettina
    Bechtold, Astrid
    Arnold, Norbert
    Preisler-Adams, Sabine
    Nestle-Kraemling, Carolin
    Zaino, Mohammad
    Loeffler, Markus
    Kiechle, Marion
    Meindl, Alfons
    Varga, Dominic
    Schmutzler, Rita K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 5887 - 5892
  • [27] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, K.
    Gershman, S.
    Lynch, H. T.
    Ghadirian, P.
    Tung, N.
    Kim-Sing, C.
    Olopade, O. I.
    Domchek, S.
    McLennan, J.
    Eisen, A.
    Foulkes, W. D.
    Rosen, B.
    Sun, P.
    Narod, S. A.
    BRITISH JOURNAL OF CANCER, 2011, 104 (09) : 1384 - 1392
  • [28] Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Rebbeck, Timothy R.
    Domchek, Susan M.
    BREAST CANCER RESEARCH, 2008, 10 (04)
  • [29] BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer
    Rosenberg, Shoshana M.
    Ruddy, Kathryn J.
    Tamimi, Rulla M.
    Gelber, Shari
    Schapira, Lidia
    Come, Steven
    Borges, Virginia F.
    Larsen, Bryce
    Garber, Judy E.
    Partridge, Ann H.
    JAMA ONCOLOGY, 2016, 2 (06) : 730 - 736
  • [30] GUIDELINES FOR MANAGING BREAST CANCER IN WOMEN WITH A BRCA1/BRCA2 GENE MUTATION OR AT HIGH RISK OF A GENE MUTATION
    Wilcken, N.
    Kirk, J.
    Nelson, A.
    Dalton, T.
    Webster, F.
    Care, O.
    Zorbas, H.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 67 - 67